RARE News
Dyne Therapeutics announces positive initial clinical data from ACHIEVE Trial in DM1 patients and DELIVER Trial in DMD patients demonstrating promise of the FORCE™ Platform in developing therapeutics for rare muscle diseases
By
admin
5 January 2024